5-HT2 receptor-mediated phosphoinositide hydrolysis in bovine ciliary epithelium

Journal of Ocular Pharmacology and Therapeutics

Volumn 19, Issue 1, 2003, Pages 55-62

  Inoue Matsuhisa, Eri ^a,b   Moroi, Sayoko E ^a   Takenaka, Hisashi ^c   Sogo, Shunji ^c   Mano, Tomiya ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b C/o Osaka Kasei Corporation ^*  (Japan)

^c Tane Memorial Eye Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; ALPHA ADRENERGIC RECEPTOR; CHLORPROMAZINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; KETANSERIN; MESULERGINE; PHOSPHOLIPASE C; SARPOGRELATE; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; SPIPERONE;

ANIMAL TISSUE; AQUEOUS HUMOR FORMATION; ARTICLE; CILIARY BODY EPITHELIUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; INTRAOCULAR PRESSURE; NONHUMAN; RABBIT; SIGNAL TRANSDUCTION;

EID: 0037327981     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076803762718114     Document Type: Article

References (35)

1. 2 antagonist, on intraocular pressure in rabbits. May, 1995; Ft. Lauderdale, FL. Invest. Ophthalmol. Vis. Sci. 1995.
2. 2 antagonist on intraocular pressure in glaucoma patients. Invest. Ophthalmol. Vis. Sci. 1995; Ft. Lauderdale, FL. 1995.
3. Chang, F.W., Burke, J.A., Potter, D.E. Mechanism of the ocular hypotensive action of ketanserin. J. Ocul. Pharmacol. 1:137-147, 1985.
4. Oh, S.J., Ha, H.J., Chi, D.Y., Lee, H.K. Serotonin receptor and transporter ligands - current status. Curr. Med. Chem. 8:999-1034, 2001.
5. Albert, P.R., Tiberi, M. Receptor signaling and structure: insights from serotonin-1 receptors. Trends Endocrinol. Metab. 12:453-460, 2001.
6. Pauwels, P.J. Diverse signalling by 5-hydroxytryptamine (5-HT) receptors. Biochem. Pharmacol. 60:1743-1750, 2000.
7. Veglio, F., De Sanctis, U., Schiavone, D., Cavallone, S., Mulatero, P., Grignolo, FM., Chiandussi, L. Evaluation of serotonin levels in human aqueous humor. Ophthalmologica. 212:160-163, 1998.
8. Martin, X.D., Brennan, M.C., Lichter, P.R. Serotonin in human aqueous humor. Ophthalmology. 95:1221-1226, 1988.
9. Martin, X.D., Malina, H.Z., Brennan, M.C., Hendrickson, P.H., Lichter, P.R. The ciliary body - the third organ found to synthesize indoleamines in humans. Eur. J. Ophthalmol. 2:67-72, 1992.
10. Tobin, A.B., Unger, W., Osborne, N.N. Evidence for the presence of serotonergic nerves and receptors in the iris-ciliary body complex of the rabbit. J. Neurosci. 8:3713-3721, 1988.
11. 3H]5-hydroxytryptamine binding to iris-ciliary body tissue of the rabbit. Invest. Ophthalmol. Vis. Sci. 36:2238-2245, 1995.
12. Chidlow, G., Nash, M.S., De Santis, L.M., Osborne, N.N. The 5-HT(1A)Receptor agonist 8-OH-DPAT lowers intraocular pressure in normotensive NZW rabbits. Exp. Eye Res. 69:587-593, 1999.
13. Tekat, D., Guler, C., Arici, M., Topalkara, A., Erdogan, H. Effect of ketanserin administration on intraocular pressure. Ophthalmologica. 215:419-423, 2001.
14. Schoenwald, R.D., Zhu, J. The ocular pharmacokinetics of ketanserin and its metabolite, ketanserinol, in albino rabbits. J. Ocul. Pharmacol. Ther. 16:481-495, 2000.
15. Mastropasqua, L., Ciancaglini, M., Carpineto, P., Costagliola, C. Ocular hypotensive effect of topical ketanserin in timolol users. Graefes Arch. Clin. Exp. Ophthalmol. 235:130-135, 1997.
16. Chiou, G.C., Li, B.H. Ocular hypotensive actions of serotonin antagonist-ketanserin analogs. J. Ocul. Pharmacol. 8:11-21, 1992.
17. Moroi, S.E., Hao, Y., Inoue-Matsuhisa, E., Pozdnyakov, N., Sitaramayya, A. Cell signaling in bovine ciliary epithelial organ culture. J. Ocular Pharmacol. Ther. 16:65-74, 2000.
18. Kass, M.A., Heuer, D.K., Higginbotham, E.J., Johnson, C.A., Keltner J.L., Miller J.P., Parris II, R.K., Wilson, M.R., Gordon M.O. The Ocular Hypertension Treatment Study, A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch. Ophthalmol. 120:701-713, 2002.
19. Yablonski, M.E., Zimmerman, T.J., Waltman, S.R., Becker, B. A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp. Eye Res. 27:135-142, 1978.
20. Toris, C.B., Tafoya, M.E., Camras, C.B., Yablonski, M.E. Effects of apraclonidine on aqueous humor dynamics in human eyes. Ophthalmology. 102:456-461, 1995.
21. Lee, D.A., Topper, J.E., Brubaker, R.F. Effect of clonidine on aqueous humor flow in normal human eyes. Exp. Eye Res. 38:239-246, 1984.
22. Oshika, T., Araie, M., Sugiyama, T., Nakajima, M., Azuma, I. Effect of bunazosin hydrochloride on intraocular pressure and aqueous humor dynamics in normotensive human eyes. Arch. Ophthalmol. 109:1569-1574, 1991.
23. Trew, D.R., Wright, L.A., Smith, S.E. Ocular responses in healthy subjects to topical bunazosin 0.3% - an alpha 1-adrenoceptor antagonist. Br. J. Ophthalmol. 75:411-413, 1991.
24. Gabelt, B.T., Millar, C.J., Kiland, J.A., Peterson, J.A., Seeman, J.L., Kaufman, P.L. Effects of serotonergic compounds on aqueous humor dynamics in monkeys. Curr. Eye Res. 23:120-127, 2001.
25. 1A receptor agonist/alpha 1-adrenoceptor antagonist, lowers intraocular pressure in NZW rabbits. Curr. Eye Res. 23:144-153, 2001.
26. Costagliola, C., Iuliano, G., Rinaldi, M., Russo, V., Scibelli, G., Mastropasqua, L. Effect of topical ketanserin administration on intraocular pressure. Br. J. Ophthalmol. 77:344-348, 1993.
27. Krupin, T., Feitl, M., Becker, B. Effect of prazosin on aqueous humor dynamics in rabbits. Arch. Ophthalmol. 98:1639-1642, 1980.
28. Wang, R.F., Lee, P.Y., Mittag, T.W., Podos, S.M., Serle, J.B. Effect of 5-methylurapidil, an alpha 1a-adrenergic antagonist and 5-hydroxytryptaminela agonist, on aqueous humor dynamics in monkeys and rabbits. Curr. Eye Res. 16:769-775, 1997.
29. Chidlow, G., Le Corre, S., Osborne, N.N. Localization of 5-hydroxytryptamine1A and 5-hydroxytryptamine7 receptors in rabbit ocular and brain tissues. Neuroscience. 87:675-689, 1998.
30. Ramage, A.G. Central cardiovascular regulation and 5-hydroxytryptamine receptors. Brain Res. Bull. 56:425-439, 2001.
31. Cravchik, A., Goldman, D. Neurochemical individuality: genetic diversity among human dopamine and serotonin receptors and transporters. Arch. Gen. Psychiatry. 57:1105-1114, 2000.
32. Walton, S.M. Advances in use of the 5-HT3 receptor antagonists. Expert Opin. Pharmacother. 1:207-223, 2000.
33. Costagliola, C., Mastropasqua, L., Capone, D., Verolino, M., Ciancaglini, M., Pisanti, N. Effect of fluoxetine on intraocular pressure in the rabbit. Exp. Eye Res. 70:551-555, 2000.
34. Osborne, N.N., Wood, J.P., Melena, J., Chao, H.M., Nash, M.S., Bron. A.J., Chidlow, G. 5-Hydroxytryptamine1A agonists: potential use in glaucoma. Evidence from animal studies. Eye. 14:454-463, 2000.
35. Moroi, S.E., Hao, Y., Sitaramayya, A. Nitric oxide attenuates alpha(2)-adrenergic receptors by ADP-ribosylation of G(i)alpha in ciliary epithelium. Invest. Ophthalmol. Vis. Sci, 42:2056-2062, 2001.